What are the recommended management options for patients with CIED-detected AHREs?
The management of patients with CIED-detected AHREs requires cardiological clinical evaluation, clinical decision-making, and follow up. OACs could be considered as a result of an individualized clinical assessment taking into account overall AHRE burden (in the range of multiple hours rather than few minutes) and specifically presence of AHRE > 24 h, individual stroke risk (CHA2DS2-VASc), predicted risk/benefit of oral anticoagulation (specifically risk of major bleeding), and informed patient preferences.